Searle/China trust agreement
Executive Summary
Searle providing $ 500,000 initial funding for trust to assist China in pharmaceutical R&D. Trust gives Searle first right of refusal for exclusive licensure of any resulting products. Company currently distributes seven products in China through the National China Pharmaceutical Corporation -- Aldactone, Metrozine, Metrozine IV, Norpace, Norpace CR, NitroDisc and Equal sweetner.